Table 3.
Baseline characteristics
| Description | Immediate entry (n = 17) | Deferred entry (n = 19) | All (n = 36) |
|---|---|---|---|
| Age (years)a | 75.6 (6.81) | 73.2 (5.01) | 74.9 (6.89) |
| Age range (years) | 67–92 | 65–83 | |
| Sex (male) | 14 (82%) | 16 (84%) | |
| RRT b (years)c | 1 (0.5–4.0) | 3 (1.0–7.0) | 2 (1.0–5.5) |
| Number of comorbiditiesc | 2 (1.0–4.5) | 3 (2.0–4.0) | 2 (1.0–4.0) |
| Diabetes | 7 (41%) | 5 (26%) | |
| Isaac’s Set Testa | 31.7 (7.4) | 30.6 (6.3) | 31.1 (6.7) |
| CORE34a | 0.48 (0.43) | 0.75 (0.57) | 0.62 (0.52) |
| KDQOL-36™ | |||
| Symptomsa | 77.1 (18.6) | 67.9 (23.1) | 72.2 (21.3) |
| Effectsa | 86.8 (12.1) | 65.8 (25.6) | 75.7 (22.7) |
| Burdena | 45.6 (27.5) | 40.8 (30.2) | 43.1 (28.7) |
| SF12 physicala | 37.3 (4.8) | 30.7 (10.46) | 33.8 (8.8) |
| SF12 mentala | 46.8 (10.7) | 51.3 (12.4) | 49.2 (11.7) |
| SHARED scorea | 11.5 (6.9)e | 8.3 (4.1)e | 9.3 (5.2) |
| University degree | 5 (29%) | 1 (5%) | |
| Household incomed | £10–20,000 (£10–60,000) | £10–20,000 (£10–70,000) | |
| Renal Unit 1 | 13 (76%) | 16 (84%) | |
aMean (standard deviation)
bRenal replacement therapy
cMedian (inter-quartile range)
dMedian, reported in increments of £10,000 (range)
eData from 6 patients in immediate group and 13 in deferred group